PUBLIC COMPANY
save$PCRXPacira BioSciences, Inc.
$PCRX36.390.00%Brisbane, CA, USupdated 22d ago
community read0 votes
🐶 often sniffed alongside
top 3pipeline
2
marketed
1
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 21Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy businessWith an internal non-opioid program nearing approval, Viatris is picking up Pacira BioSciences for a broader pain portfolio and the associated commercial infrastructure.biospace · 1mo ago
- STAT+: Roche goes beyond licensing in deal with Chinese biotechRoche is partnering with Chinese startup Defand Therapeutics to discover new medicines.stat · 1mo ago
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that